Literature DB >> 8149668

The significance of the pre-challenge immune status of mice for development of retrovirus-induced immunodeficiency syndrome (MAIDS).

J H Pavlovitch1, M Rizk-Rabin, F Picard, M Marussig, A Halbreich.   

Abstract

The effects of vaccination with RNA-free viral pseudoparticles, preinfection with non-pathogenic ecotropic virus, and induction of tolerance to viral proteins in newborns on the outcome of murine immunodeficiency syndrome (MAIDS) were studied. The parameters used to follow disease progression were: lymphopenia, circulating B and T8 cells, serum IgG and IgM levels, lymphoproliferation and skin graft rejection. Immunization with RNA-free viral pseudoparticles had no effect on any of these parameters. Preinfection of adults with ecotropic virus and the induction of tolerance in newborns to virus antigens both attenuated the early symptoms of viral infection and delayed the onset of immunodeficiency and lymphoproliferation in some mice, but did not significantly alter the number of deaths due to MAIDS. Failure of immune-based therapy to produce successful protection against MAIDS suggests that immune destruction caused by the persistent virus rather than hyperimmune activity is the main pathogenic factor in this disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149668      PMCID: PMC1534529          DOI: 10.1111/j.1365-2249.1994.tb06231.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development.

Authors:  C Martínez-A; M A Marcos; A de la Hera; C Marquez; J M Alonso; M L Toribio; A Coutinho
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

2.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

3.  Severe immunodeficiency disease induced by a defective murine leukaemia virus.

Authors:  D C Aziz; Z Hanna; P Jolicoeur
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

4.  Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome.

Authors:  S K Chattopadhyay; H C Morse; M Makino; S K Ruscetti; J W Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.

Authors:  H J Alter; J W Eichberg; H Masur; W C Saxinger; R Gallo; A M Macher; H C Lane; A S Fauci
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

6.  The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome.

Authors:  C Simard; P Jolicoeur
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

7.  Zidovudine (azido dideoxythymidine) inhibits characteristic early alterations of lymphoid cell populations in retrovirus-induced murine AIDS.

Authors:  D Portnoi; A M Stall; D Schwartz; T C Merigan; L A Herzenberg; T Basham
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

8.  In vivo immunologic deficits in mice with murine acquired immunodeficiency syndrome and the effect of LP-BM5 infection on rejection of skin from infected mice.

Authors:  A S Rosenberg; T G Maniero; H C Morse
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

9.  Autoimmunity after induction of neonatal tolerance to alloantigens: role of B cell chimerism and F1 donor B cell activation.

Authors:  S Luzuy; J Merino; H Engers; S Izui; P H Lambert
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.